One in four U.S. adults, representing more than 66 million people, has used AI tools or chatbots for health information or advice, according to research from the West Health-Gallup Center on Healthcare. Yet a 2026 self-selected industry survey of 300 dental professionals across the U.S. and Canada found that 40 percent of respondents who discontinued an AI tool had stopped using it within three months. These figures point to an uncomfortable reality for dentistry: the industry is getting better at developing technology than it is at ensuring technology deserves a place in clinical practice.
New features and impressive demonstrations may attract attention, but they do not automatically improve patient care. Until the industry takes that distinction seriously, its technology boom risks producing more products than lasting progress. Dentistry does not lack innovation.
Artificial intelligence is entering diagnostic workflows, digital imaging is expanding treatment-planning capabilities, and guided surgery, chairside 3D printing and connected systems are changing how practices operate. A 2026 review in the Journal of the California Dental Association describes a field in which technologies are becoming increasingly available, while adoption remains shaped by education, economics, infrastructure and professional culture. The problem is, availability is often treated as a sign of progress.
The more technology the industry introduces, the more carefully it must distinguish genuine clinical value from novelty. For clinicians, that distinction has real financial and operational consequences. Manufacturers may promise greater precision, efficiency, and better decision-making, but dental practices must absorb the cost of purchasing equipment, training staff, adapting workflows, and managing disruption.
A product demonstration can make a technology look indispensable. The daily reality of using it may tell a different story. Before practices invest, they need evidence that an innovation addresses a meaningful problem, performs as intended and offers a benefit that justifies its cost and complexity.
The 2026 Dental Reviewed survey reinforces this point, identifying cost and integration among the leading reasons dental professionals stopped using AI tools. These are not minor implementation issues. They expose a fundamental weakness in how technology can be brought to market: a product may work as designed and still fail in practice.
Extract — continue reading at the source.
